×
News Home

Where Does Ardelyx Inc (ARDX) Stock Fall in the Biotechnology Field After It Has Gained 9.68% This Week?

Friday, August 19, 2022 10:52 AM | InvestorsObserver Analysts
Where Does Ardelyx Inc (ARDX) Stock Fall in the Biotechnology Field After It Has Gained 9.68% This Week?

A rating of 93 puts Ardelyx Inc (ARDX) near the top of the Biotechnology industry according to InvestorsObserver. Ardelyx Inc's score of 93 means it scores higher than 93% of stocks in the industry. Ardelyx Inc also received an overall rating of 81, putting it above 81% of all stocks. Biotechnology is ranked 27 out of the 148 industries.

Overall Score - 81
ARDX has an Overall Score of 81. Find out what this means to you and get the rest of the rankings on ARDX!

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. InvestorsObserver makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts.
Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Ardelyx Inc Stock Today?

Ardelyx Inc (ARDX) stock is trading at $1.02 as of 10:52 AM on Friday, Aug 19, a decline of -$0.04, or -3.75% from the previous closing price of $1.06. The stock has traded between $1.01 and $1.06 so far today. Volume today is light. So far 539,075 shares have traded compared to average volume of 1,970,604 shares. Click Here to get the full Stock Report for Ardelyx Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App